Coreline Soft Participates in Korean Society of Radiation Oncology... Exhibits AVIEW RT ACS

Coreline Soft, a medical artificial intelligence (AI) specialist company led by CEOs Jin-Kuk Kim and Jung-Pil Choi, announced on the 11th that it will exhibit ‘AVIEW RT ACS’ at the ‘2023 Korean Society of Radiation Oncology Spring Conference.’

Celebrating its 41st anniversary this year, the Korean Society of Radiation Oncology was established to promote public health through radiation therapy and to advance the field of radiation oncology. Radiation therapy is an essential treatment for cancer patients, and the society supports various areas including expert training, practical education, academic activities, clinical practice, and research. This year’s spring conference will be held over two days, May 11 and 12, at the Paradise Hotel in Busan.

At this spring conference, where renowned industry experts gather, Coreline Soft plans to showcase its AI-based automatic contouring solution, AVIEW RT ACS.

The primary goal of radiation oncology treatment is to deliver radiation accurately to the target to eliminate cancer cells while minimizing the impact on surrounding normal organs. To achieve this, the contouring process, which involves delineating not only the target but also the normal organs during the treatment planning stage, is essential.

In this process, the AI automatic contouring feature of AVIEW RT ACS is utilized. This feature uses AI trained on a large amount of expert-contoured ground truth data to automatically delineate patient data. Additionally, experts can further refine the contours, enhancing the precision and efficiency of radiation therapy.

AVIEW RT ACS segments organs in four major body regions: head, neck, breast, abdomen, and pelvis, and supports DICOM-RT from the segmented masks, allowing direct application to RT Plan (treatment planning). DICOM (Digital Imaging and Communications in Medicine) is the international standard file format for medical imaging data, and DICOM-RT is an extended format specialized for radiation oncology. DICOM facilitates easy clinical practice by storing various additional information such as ultrasound, MRI images, and patient medical information in a single file. The product secured product stability and reliability by obtaining the U.S. FDA 501(k) clearance last year.

A company representative stated, “AVIEW RT ACS is a product that simultaneously offers cancer patients the opportunity for fast and accurate treatment and improves the convenience of medical staff. It enjoys high trust from hospitals currently using it. As a product that supports experts in enhancing the precision and efficiency of radiation therapy, we will provide consulting at this conference to achieve optimal performance in various product usage environments.”

They added, “Our company developed AVIEW LCS PLUS, the world’s first simultaneous diagnosis solution for thoracic diseases, and is leading the medical AI market by supplying solutions to domestic and international lung cancer screening projects in Korea, six European countries, and more.”

Meanwhile, Coreline Soft has completed a pre-IPO round worth 10.6 billion KRW and is preparing for a KOSDAQ market listing through a merger with Shinhan No.7 SPAC.

This content was produced with the assistance of AI translation services.